Corrigendum: Time interval from diagnosis to treatment of brain metastases with stereotactic radiosurgery is not associated with radionecrosis or local failure

Frontiers in Oncology

Oncology

Matthew Witten¹  Paul Duic²  Marissa Barbaro²  Lee Tessler³  David Ebling⁴  Todd Carpenter⁴  Christopher Mendez⁴  Jonathan W. Lischalk⁵  Jonathan A. Haas⁵  Michael C. Repka⁶  Meredith Akerman⁷  Justin Leu⁸ 

[1] Department of Medical Physics, Perlmutter Cancer Center at New York University (NYU) Long Island, Mineola, NY, United States;Department of Neurology, New York University (NYU) Long Island School of Medicine, Mineola, NY, United States;Department of Neurosurgery, Perlmutter Cancer Center at New York University (NYU) Long Island, Mineola, NY, United States;Department of Radiation Oncology, Perlmutter Cancer Center at New York University (NYU) Long Island, Mineola, NY, United States;Department of Radiation Oncology, Perlmutter Cancer Center at New York University (NYU) Long Island, Mineola, NY, United States;NYCyberKnife at Perlmutter Cancer Center – Manhattan, New York, NY, United States;Department of Radiation Oncology, University of North Carolina School of Medicine, Chapel Hill, NC, United States;Division of Health Services Research, New York University (NYU) Long Island School of Medicine, Mineola, NY, United States;Renaissance School of Medicine, Stony Brook University, Stony Brook, NY, United States;

关键词: stereotactic radiosurgery;    brain metastases;    immunotherapy;    radionecrosis;    treatment delays;    cancer;    radiation therapy;    radiation necrosis;   

DOI  :  10.3389/fonc.2023.1192726

 received in 2023-03-23, accepted in 2023-03-29,  发布年份 2023

来源: Frontiers

【 授权许可】

Unknown   
Copyright © 2023 Leu, Akerman, Mendez, Lischalk, Carpenter, Ebling, Haas, Witten, Barbaro, Duic, Tessler and Repka